Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 23
Phase 31
Phase 42

Trial Status

Completed3
Recruiting3
Other2

Role Distribution

Principal Investigator3
Other Roles5
PI Rate38%

Activity Timeline

Clinical Trials (8)

NCT06084819Phase 2Recruiting
Clinical Study of Venetoclax Combined With CACAG Regimen in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
Relapsed/Refractory Acute Myeloid Leukemia
StudychairStart date: 2023-08-01
NCT06119256Phase 1Recruiting
Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT
EBV Infection After Allogenic HSCT
PrincipalinvestigatorStart date: 2023-08-01
NCT06135922Phase 1Recruiting
Clinical Study of EBV-TCR-T Cells for EBV-associated Hemophagocytic Lymphohistiocytosis or EBV Infection
EBV InfectionEBV-associated Hemophagocytic Lymphohistiocytosis
PrincipalinvestigatorStart date: 2023-08-01
NCT06068621Phase 2Completed
Venetoclax Plus CACAG Regimen for Newly Diagnosed Acute Myeloid Leukemia
Acute Myeloid Leukemia
StudychairStart date: 2023-03-01
NCT05166967Phase 3Completed
Targeted Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation
Haploidentical Hematopoietic Stem Cell Transplantation
PrincipalinvestigatorStart date: 2022-01-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (8)

Showing 8 of 8 trials

NCT06084819Phase 2StudyChair

Clinical Study of Venetoclax Combined With CACAG Regimen in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Relapsed/Refractory Acute Myeloid Leukemia
Recruiting
NCT06119256Phase 1PrincipalInvestigator

Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT

EBV Infection After Allogenic HSCT
Recruiting
NCT06135922Phase 1PrincipalInvestigator

Clinical Study of EBV-TCR-T Cells for EBV-associated Hemophagocytic Lymphohistiocytosis or EBV Infection

EBV InfectionEBV-associated Hemophagocytic Lymphohistiocytosis
Recruiting
NCT06068621Phase 2StudyChair

Venetoclax Plus CACAG Regimen for Newly Diagnosed Acute Myeloid Leukemia

Acute Myeloid Leukemia
Completed
NCT05166967Phase 3PrincipalInvestigator

Targeted Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation

Haploidentical Hematopoietic Stem Cell Transplantation
Completed
NCT05214066Phase 2StudyDirector

Efficacy and Safety Study of 4-Day ATG Regimen for Prophylaxis of aGVHD in Matched Sibling Donor PBSCT

aGVHDcGVHD
Unknown
NCT02677181Phase 4StudyDirector

Efficacy and Safety Study of ATG for Prophylaxis of aGVHD in Matched Sibling Donor PBSCT

aGVHD
Completed
NCT02784561Phase 4StudyDirector

Study of Busulfan and FLAG Conditioning Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

Leukemia
Unknown

All 8 trials loaded